Page 108 - 20211214_OHKF_Health_Finance_Research_Report_E (1)
P. 108

Incorporating cost-effective contracting

            Policy clarity and definition of the contracting process (in other words, the payment
            system and financing mechanism between purchasers and providers) is a key component of
            strategic purchasing (Klasa et al., 2018). An ideal contract will have terms and criteria, as well
            as measurements of its effectiveness, that are based on evidence, premised on the
            availability of a health system’s data on health status, health needs of its populations, and the
            efficiency of existing health programmes and service models. Provider payment systems
            must align with benefit package design, and due consideration should be given to the
            transfer of risk from the purchaser to service providers and communication to both
            parties, as well as patients (Nachtnebel et al., 2015). Risk-sharing mechanisms are not
            explicit and the Director of Audit pointed out the need to improve risk management.


            While there is no clear definition of “good contracting” within Hong Kong’s existing PPP
            practice, a number of supply-side and demand-side factors have not been
            strategically addressed to promote PPP participation from providers and users. This
            contributes to a lower participation of providers than intended. Figure 3.12 summarises how
            various supply-side prohibitors such as heavy administrative processes, and demand-side
            factors such as unattractive subsidies for patients, contribute to less effective PPPs. In
            general, the two primary care PPPs experienced similar barriers to participation, in particular,
            unattractive provider incentives and restricted drug coverage for the GOPC-PPP programme
            (Wong et al., 2015).



               Figure 3.12

                 Factors that render less effective PPPs in Hong Kong




                   SUPPLY-SIDED PROHIBITORS                DEMAND-SIDED PROHIBITORS


                                             Lack of support
                         Top-down                                       Design of
                     decision -making lacks  (IT, financial) and      the programme
                       involvement from      communication          unsynchronised with
                       the private sector     platforms to          patients’ behaviour
                                            the private sector


                     Heavy administrative    Lack of referral       Unattractive subsidy
                          process              pathway &             to patients & the
                        (registration,       integration with          possibility of
                     reimbursement. etc.)   the public sector          co-payment




                          Inflexible
                       contractual terms
                    hindering care from the
                        private sector
















       106
   103   104   105   106   107   108   109   110   111   112   113